Renee Sangrigoli, MD
Advanced Heart Failure and Transplant Cardiology · Doylestown, PANPI 1922007079
Payments from drug & device makers
Across 861 payments — averaging $1377.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$492K
- Boehringer Ingelheim Pharma GmbH & Co.kg$115K
- Merck$106K
- Bayer$99K
- AstraZeneca$92K
- Eli Lilly$71K
- plus $211K from 20 others
Across 1 payment — averaging $1195.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 425 | $491,924 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 27 | $115,382 |
| Merck | 32 | $105,780 |
| Bayer | 47 | $98,621 |
| AstraZeneca | 23 | $92,052 |
| Eli Lilly | 6 | $70,626 |
| Medical Device Business Services, Inc. | 32 | $61,802 |
| Medtronic(2 entities) | 29 | $53,740 |
| Boehringer Ingelheim International GmbH | 164 | $49,367 |
| Amgen | 8 | $14,444 |
| Astrazeneca UK Limited | 4 | $12,670 |
| Sanofi US Services Inc. | 3 | $10,000 |
| Janssen Research & Development, LLC | 2 | $4,372 |
| Actelion Pharmaceuticals US, Inc. | 9 | $3,031 |
| Actelion Pharmaceuticals, Ltd | 3 | $950 |
| Novartis | 16 | $324 |
| E.r. Squibb & Sons, L.L.C. | 10 | $153 |
| Johnson & Johnson | 6 | $95 |
| Boston Scientific | 3 | $85 |
| Pfizer | 4 | $64 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Atricure, Inc. | 1 | $30 |
| Amarin Pharma, Inc. | 2 | $29 |
| Boehringer Ingelheim | 1 | $29 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
How this compares
$1,185,637 in reported general payments places this provider in the 95th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.
See all advanced heart failure and transplant cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Doylestown
- Anjali OwensPhiladelphia$1.7M
- Kenneth MarguliesPhiladelphia$1.7M
- Donald HaasAbington$1.4M
- Steven DomskyWynnewood$1.1M
- John BoehmerHershey$1M
- Anjali VaidyaPhiladelphia$805K
- Amresh RainaPittsburgh$767K
- Brendan CarryDanville$693K
- Ravi RamaniPittsburgh$608K
- Matthew LanderPittsburgh$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.